Showing results (1231-1240 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|November 2, 2018
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United StatesEytan Stein, Jipan Xie, Emilie Duchesneau, et al.Pharmacoeconomics|October 28, 2016
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An UpdateSpencer M Vale, Dane Hill, Steven R FeldmanPharmacoeconomics|December 13, 2016
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalLesley Uttley, Sophie Whyte, Timothy Gomersall, et al.Pharmacoeconomics|December 9, 2016
Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15Christine Mpundu-Kaambwa, Gang Chen, Remo Russo, et al.Pharmacoeconomics|December 9, 2016
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin LymphomaKelly Fust, Xiaoyan Li, Michael Maschio, et al.Pharmacoeconomics|December 16, 2016
Economic Studies in Motor Neurone Disease: A Systematic Methodological ReviewAlan Moore, Carolyn A Young, Dyfrig A HughesPharmacoeconomics|February 20, 2008
Projecting vaccine efficacy: accounting for geographic strain variationsJohnie Rose, Mendel E SingerPharmacoeconomics|February 20, 2008
Community and patient values for preventing herpes zosterTracy A Lieu, Ismael Ortega-Sanchez, G Thomas Ray, et al.Pharmacoeconomics|March 29, 2008
Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventionsSanjoy Roy, S Suresh MadhavanPharmacoeconomics|March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease InterventionsPei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.Pageof 336